US Stock MarketDetailed Quotes

LABP Landos Biopharma

Watchlist
  • 22.4450
  • +0.2400+1.08%
Trading May 14 11:41 ET
70.16MMarket Cap-5611P/E (TTM)

Landos Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-42.00%29M
-15.55%37.5M
-15.55%37.5M
-11.50%42.47M
-19.76%44.74M
-32.24%50.01M
-51.14%44.4M
-51.14%44.4M
-53.26%47.99M
-51.57%55.75M
-Cash and cash equivalents
-35.89%29M
2.34%37.5M
2.34%37.5M
46.84%42.41M
128.93%44.05M
300.82%45.24M
341.18%36.64M
341.18%36.64M
61.40%28.88M
2.96%19.24M
-Short-term investments
----
--0
--0
-99.68%62K
-98.12%687K
-92.38%4.76M
-90.60%7.76M
-90.60%7.76M
-77.46%19.11M
-62.14%36.51M
Restricted cash
--50K
--50K
--50K
--50K
----
----
--0
--0
----
----
Other current assets
-28.52%842K
-42.30%491K
-42.30%491K
-52.57%710K
-32.27%1.55M
-66.94%1.18M
-32.78%851K
-32.78%851K
-9.00%1.5M
-11.97%2.29M
Total current assets
-41.59%29.9M
-15.94%38.04M
-15.94%38.04M
-12.65%43.23M
-20.25%46.29M
-33.84%51.18M
-50.89%45.25M
-50.89%45.25M
-52.56%49.49M
-50.70%58.04M
Non current assets
Net PPE
----
----
----
----
----
----
----
----
--0
--0
-Gross PPE
----
----
----
----
----
----
----
----
--575K
--1.04M
-Accumulated depreciation
----
----
----
----
----
----
----
----
---575K
---1.04M
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-41.59%29.9M
-15.94%38.04M
-15.94%38.04M
-12.65%43.23M
-20.25%46.29M
-34.05%51.18M
-51.28%45.25M
-51.28%45.25M
-52.91%49.49M
-50.94%58.04M
Liabilities
Current liabilities
Payables
-31.90%1.57M
-59.97%1.38M
-59.97%1.38M
-64.58%1.14M
-78.16%1.03M
-76.56%2.3M
-73.39%3.44M
-73.39%3.44M
-68.32%3.2M
-55.91%4.71M
-accounts payable
-31.90%1.57M
-59.97%1.38M
-59.97%1.38M
-64.58%1.14M
-78.16%1.03M
-76.56%2.3M
-73.39%3.44M
-73.39%3.44M
-68.32%3.2M
-55.91%4.71M
Current accrued expenses
178.03%5.18M
81.39%4.87M
81.39%4.87M
95.11%4.43M
10.39%1.99M
-67.20%1.86M
-27.44%2.69M
-27.44%2.69M
212.81%2.27M
13.14%1.8M
Current liabilities
62.07%6.74M
2.07%6.25M
2.07%6.25M
1.66%5.57M
-53.69%3.02M
-73.17%4.16M
-63.14%6.12M
-63.14%6.12M
-50.65%5.48M
-48.04%6.51M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
62.07%6.74M
2.07%6.25M
2.07%6.25M
1.66%5.57M
-53.69%3.02M
-73.17%4.16M
-63.14%6.12M
-63.14%6.12M
-51.03%5.48M
-48.66%6.51M
Shareholders'equity
Share capital
-90.06%31K
-22.50%31K
-22.50%31K
-92.31%31K
-92.31%31K
-22.58%312K
-90.07%40K
-90.07%40K
0.50%403K
1.00%403K
-common stock
-90.06%31K
-22.50%31K
-22.50%31K
-92.31%31K
-92.31%31K
-22.58%312K
-90.07%40K
-90.07%40K
0.50%403K
1.00%403K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-17.78%-164.26M
-16.44%-155.36M
-16.44%-155.36M
-16.42%-149.24M
-19.19%-143.38M
-27.93%-139.46M
-41.72%-133.43M
-41.72%-133.43M
-73.11%-128.2M
-95.77%-120.3M
Paid-in capital
0.69%187.38M
8.43%187.12M
8.43%187.12M
8.64%186.88M
8.62%186.63M
8.71%186.09M
1.37%172.58M
1.37%172.58M
2.73%172.02M
3.00%171.82M
Gains losses not affecting retained earnings
----
--0
--0
99.53%-1K
98.21%-7K
116.92%79K
74.67%-57K
74.67%-57K
-261.07%-211K
-176.06%-392K
Total stockholders'equity
-50.76%23.15M
-18.76%31.79M
-18.76%31.79M
-14.43%37.66M
-16.03%43.27M
-24.28%47.02M
-48.69%39.13M
-48.69%39.13M
-53.14%44.01M
-51.21%51.53M
Total equity
-50.76%23.15M
-18.76%31.79M
-18.76%31.79M
-14.43%37.66M
-16.03%43.27M
-24.28%47.02M
-48.69%39.13M
-48.69%39.13M
-53.14%44.01M
-51.21%51.53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -42.00%29M-15.55%37.5M-15.55%37.5M-11.50%42.47M-19.76%44.74M-32.24%50.01M-51.14%44.4M-51.14%44.4M-53.26%47.99M-51.57%55.75M
-Cash and cash equivalents -35.89%29M2.34%37.5M2.34%37.5M46.84%42.41M128.93%44.05M300.82%45.24M341.18%36.64M341.18%36.64M61.40%28.88M2.96%19.24M
-Short-term investments ------0--0-99.68%62K-98.12%687K-92.38%4.76M-90.60%7.76M-90.60%7.76M-77.46%19.11M-62.14%36.51M
Restricted cash --50K--50K--50K--50K----------0--0--------
Other current assets -28.52%842K-42.30%491K-42.30%491K-52.57%710K-32.27%1.55M-66.94%1.18M-32.78%851K-32.78%851K-9.00%1.5M-11.97%2.29M
Total current assets -41.59%29.9M-15.94%38.04M-15.94%38.04M-12.65%43.23M-20.25%46.29M-33.84%51.18M-50.89%45.25M-50.89%45.25M-52.56%49.49M-50.70%58.04M
Non current assets
Net PPE ----------------------------------0--0
-Gross PPE ----------------------------------575K--1.04M
-Accumulated depreciation -----------------------------------575K---1.04M
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -41.59%29.9M-15.94%38.04M-15.94%38.04M-12.65%43.23M-20.25%46.29M-34.05%51.18M-51.28%45.25M-51.28%45.25M-52.91%49.49M-50.94%58.04M
Liabilities
Current liabilities
Payables -31.90%1.57M-59.97%1.38M-59.97%1.38M-64.58%1.14M-78.16%1.03M-76.56%2.3M-73.39%3.44M-73.39%3.44M-68.32%3.2M-55.91%4.71M
-accounts payable -31.90%1.57M-59.97%1.38M-59.97%1.38M-64.58%1.14M-78.16%1.03M-76.56%2.3M-73.39%3.44M-73.39%3.44M-68.32%3.2M-55.91%4.71M
Current accrued expenses 178.03%5.18M81.39%4.87M81.39%4.87M95.11%4.43M10.39%1.99M-67.20%1.86M-27.44%2.69M-27.44%2.69M212.81%2.27M13.14%1.8M
Current liabilities 62.07%6.74M2.07%6.25M2.07%6.25M1.66%5.57M-53.69%3.02M-73.17%4.16M-63.14%6.12M-63.14%6.12M-50.65%5.48M-48.04%6.51M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 62.07%6.74M2.07%6.25M2.07%6.25M1.66%5.57M-53.69%3.02M-73.17%4.16M-63.14%6.12M-63.14%6.12M-51.03%5.48M-48.66%6.51M
Shareholders'equity
Share capital -90.06%31K-22.50%31K-22.50%31K-92.31%31K-92.31%31K-22.58%312K-90.07%40K-90.07%40K0.50%403K1.00%403K
-common stock -90.06%31K-22.50%31K-22.50%31K-92.31%31K-92.31%31K-22.58%312K-90.07%40K-90.07%40K0.50%403K1.00%403K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -17.78%-164.26M-16.44%-155.36M-16.44%-155.36M-16.42%-149.24M-19.19%-143.38M-27.93%-139.46M-41.72%-133.43M-41.72%-133.43M-73.11%-128.2M-95.77%-120.3M
Paid-in capital 0.69%187.38M8.43%187.12M8.43%187.12M8.64%186.88M8.62%186.63M8.71%186.09M1.37%172.58M1.37%172.58M2.73%172.02M3.00%171.82M
Gains losses not affecting retained earnings ------0--099.53%-1K98.21%-7K116.92%79K74.67%-57K74.67%-57K-261.07%-211K-176.06%-392K
Total stockholders'equity -50.76%23.15M-18.76%31.79M-18.76%31.79M-14.43%37.66M-16.03%43.27M-24.28%47.02M-48.69%39.13M-48.69%39.13M-53.14%44.01M-51.21%51.53M
Total equity -50.76%23.15M-18.76%31.79M-18.76%31.79M-14.43%37.66M-16.03%43.27M-24.28%47.02M-48.69%39.13M-48.69%39.13M-53.14%44.01M-51.21%51.53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg